Symptomatic Remission Determines Functional Improvement and Quality of Life in Schizophrenia

Basit Öğe Kaydı
dc.contributor.authorKokacya, Mehmet Hanifi
dc.contributor.authorVirit, Osman
dc.contributor.authorCopoglu, Umit Sertan
dc.contributor.authorSavas, Haluk
dc.contributor.authorAri, Mustafa
dc.contributor.authorBahceci, Bulent
dc.date.accessioned2024-09-18T20:56:52Z
dc.date.available2024-09-18T20:56:52Z
dc.date.issued2016
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractIntroduction: Schizophrenia is a chronic illness that negatively affects the quality of life and psychosocial functions. Defined criteria to assess remission in schizophrenia are considered to be useful in the longterm follow-up of patients and in discriminating diagnostic factors. This study investigated the quality of life and functionality in schizophrenia patients in symptomatic remission (R-Sch) and not in remission (NonR- Sch). Methods: Sociodemographic data were collected for 40 R-Sch and 40 Non-R-Sch patients, and the following scales were administered: the Clinical Global Impression-Severity (CGI-S) Scale; Positive and Negative Syndrome Scale (PANSS), World Health Organization Quality of Life Questionnaire-Short Form, Turkish Version (WHOQOL-BREF-TR), Quality of Life Scale for Schizophrenia Patients (QLS), and Global Assessment of Functioning Scale (GAF). Results: The total and all subscale scores of PANSS and the CGI-S score were significantly lower in the R-Sch group than in the NonR- Sch group, whereas the GAF scores and all subscales of QLS and WHOQOL-BREF-TR were significantly higher. Conclusion: This study demonstrates that improvement in symptoms in schizophrenia patients improves quality and functionality in all areas of life, suggesting that an improvement in symptoms is the most important determinant of functional recovery in the treatment of schizophrenia.en_US
dc.identifier.doi10.5152/npa.2016.11327
dc.identifier.endpage333en_US
dc.identifier.issn1300-0667
dc.identifier.issn1309-4866
dc.identifier.issue4en_US
dc.identifier.pmid28360807en_US
dc.identifier.scopus2-s2.0-85006459481en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage328en_US
dc.identifier.urihttps://doi.org/10.5152/npa.2016.11327
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12142
dc.identifier.volume53en_US
dc.identifier.wosWOS:000391572500008en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofNoropsikiyatri Arsivi-Archives of Neuropsychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSchizophreniaen_US
dc.subjectsymptomatic remissionen_US
dc.subjectquality of lifeen_US
dc.titleSymptomatic Remission Determines Functional Improvement and Quality of Life in Schizophreniaen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
105.07 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu